Radius Recycling's 3PR™ Services: Enhancing Material Recovery and Landfill Diversion for Nation's Largest Brands
Originally published in Radius Recycling's 2024 Sustainability Report
Recycling plays a crucial role in the sustainability efforts of any business.
Our 3PR™ Third Party Recycling services cater to the growing demand from companies, organizations, and other entities to enhance their recycling rates and materials recovery. The 3PR™ portfolio advances manufacturing and retail productivity, minimizes waste sent to landfills, and mitigates industrial carbon emissions for our partners.
Our comprehensive services examine the supply chains of retail, manufacturing, and industrial customers to identify and leverage materials recovery and recycling strategies for a growing array of material types. We deliver value to our customers through the income generated from recycling efforts, while also reducing the environmental impact of their activities. Through our diversified supply channels, we provide tailored recycling and logistical solutions that enable businesses to efficiently handle both post-industrial and post-consumer materials.
Helping The Home Depot® Advance Circularity
Since 2014, Radius has partnered with The Home Depot to support their goals around circularity and commitment to recycling and reuse. Our 3PR™ teams manage recycling programs across The Home Depot's network for ferrous and nonferrous metals, cardboard, expanded polystyrene (EPS), and plastic film, helping to keep valuable materials out of landfills.
Railcar Parts Management with TTX Company (TTX)
With a fleet of more than 175,000 railcars throughout the U.S., Mexico and Canada, TTX is a critical part of North America's transportation infrastructure. As a leader in railcar retirement services, Radius has supported TTX through management of its end-of-life railcar assets since 2008, and more recently by servicing 20 of the company's railcar maintenance locations.
Through our comprehensive 3PR™ services, Radius not only recycles valuable metals from TTX end-of-life assets, but we extract usable rail parts and return them to the company for reconditioning and reuse. In the last five years alone, Radius has processed approximately 85,000 gross tons (GT) of railcar materials for TTX, ensuring valuable resources are responsibly recycled and remain at the center of the circular economy.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 hours ago
- Yahoo
28bio Announces Nexon™ Neurotechnology Platform Powered by Engineered Human Brains
Exhibits complex neurological processes—including memory, learning, and cognition—and predicts human outcomes in preclinical drug development NEW ORLEANS, June 9, 2025 /PRNewswire/ -- 28bio today announced the Nexon™ neurotechnology platform—a major advancement in understanding human brain function. The platform integrates tissue engineering, neural interfacing and AI to engineer human brains at-scale and replicate complex neurological processes. The Nexon™ platform is now being used to improve the prediction of therapeutic efficacy and toxicity in humans, with several of the world's largest pharma companies already integrating Nexon™ into their drug development workflows. The Nexon™ platform also incorporates Organoid Intelligence (OI). The growing field of OI combines human brain organoids with brain-machine interfaces to model memory, learning, and cognition in vitro, offering novel functional cognitive biomarkers with the potential to reshape drug development in neurodegenerative disorders including Alzheimer's disease. Neurological drug development faces some of the highest failure rates in the pharmaceutical industry, due to poor translatability of animal models. Despite promising preclinical study results, many therapies ultimately fail in humans—contributing to a growing neurological health crisis and need for more predictive, human-relevant models. "We engineer human brains capable of elucidating the complexity of neurological processes and produce predictive data needed to change the trajectory of neurological drug development," said Alif Saleh, CEO of 28bio. "Industry and regulators are urgently asking for solutions to develop better neurological drugs faster and cheaper." About 28bio28bio is a neurotechnology company engineering human brains at-scale exhibiting memory, learning, and cognitive functions. Its Nexon™ platform integrates tissue engineering, neural interfacing, and AI to reverse today's neurological health crisis by improving the ability to predict which therapies will work in humans. 28bio is committed to advancing ethical standards in the development of brain organoid technology and engineered human cognition. For more information, visit View original content to download multimedia: SOURCE 28bio Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
3 days ago
- Yahoo
Nucor Corporation (NUE): A Bull Case Theory
We came across a bullish thesis on Nucor Corporation (NUE) on Business Model Mastery's Substack. In this article, we will summarize the bulls' thesis on NUE. Nucor Corporation (NUE)'s share was trading at $108.94 as of 29th May. NUE's trailing and forward P/E were 19.20 and 14.14 respectively according to Yahoo Finance. A steel rod, bent and contoured to the exact specifications of the company. Nucor stands out as a vertically integrated steel producer operating through three synergistic segments—steel mills, steel products, and raw materials—underpinned by its control of critical inputs, including 3.5 million metric tons of direct reduced iron (DRI) and 18 million tons of recycled scrap annually. This integration enables tight cost control and reliable supply chains. The company's strategic focus on high-value products like insulated panels, overhead doors, and custom racking systems has driven meaningful margin expansion, further bolstered by premium-branded offerings such as ECONIQ™ and AEOS™, which meet growing demand in low-carbon and seismic-resistant construction markets. Nucor's operational flexibility is a core strength, with nearly all production relying on electric arc furnaces (EAFs) that offer rapid scalability and deliver 60–70% lower carbon emissions compared to traditional blast furnaces. Its micro mill strategy and regional footprint enhance both cost efficiency and environmental performance. The company's unique decentralized culture, with just 200 employees at headquarters overseeing over 32,000 teammates, empowers plant-level decision-making and incentivizes performance, driving innovation and responsiveness. This structure supports its aggressive capex-driven growth strategy—$11.8 billion deployed over the past three years, with 63% allocated to capacity expansion and 37% to acquisitions. These investments target fast-growing sectors such as data centers, renewable energy, and automated warehousing, positioning Nucor for long-term structural advantage. The company's integrated model, flexible operations, and disciplined capital deployment collectively support a compelling narrative of margin growth, sustainable production leadership, and strategic evolution in key demand verticals. For a comprehensive analysis of another standout stock covered by the same author, we recommend reading our summary of their of Sanofi (SNY). Since our coverage, the stock is up 4.7%. Nucor Corporation (NUE) is not on our list of the 30 Most Popular Stocks Among Hedge Funds. As per our database, 51 hedge fund portfolios held NUE at the end of the first quarter which was 50 in the previous quarter. While we acknowledge the potential of NUE as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock. Disclosure: None. This article was originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
3 days ago
- Yahoo
Nanalysis Announces Fully Subscribed $2 Million Note Offering
/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/ CALGARY, AB, June 6, 2025 /CNW/ - Nanalysis Scientific Corp. (the "Company" or "Nanalysis") (TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), is pleased to announce that its previously disclosed offering of 12% unsecured promissory notes (the "Notes") for aggregate gross proceeds of $2,000,000 (the "Offering") is now fully subscribed. As part of the Offering, the Company will issue an aggregate of 1,600,000 bonus common shares to subscribers. These shares will be subject to a four month hold period commencing from the date of issuance thereof, in accordance with applicable securities laws. Closing of the Offering is scheduled to occur on or about June 11, 2025, and remains subject to customary closing conditions, including receipt of all necessary corporate and regulatory approvals, including TSX Venture Exchange ("TSXV") acceptance. For further information regarding the Offering, please refer to the Company's news release dated June 6, 2025, available on SEDAR+ at About Nanalysis Scientific Corp. (TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1) Nanalysis Scientific Corp. in operates two primary business segments: Scientific Equipment and Security Services. Within its Scientific Equipment business is what the Company terms "MRI and NMR for industry". The Company develops and manufactures portable Nuclear Magnetic Resonance (NMR) spectrometers or analyzers for laboratory and industrial markets. The NMReady-60™ was the first full-feature portable NMR spectrometer in a single compact enclosure requiring no liquid helium or any other cryogens. The Company has followed up that initial offering with new products and continues to have a strong innovation pipeline. In 2020, the Company announced the launch of its 100MHz platform, which has the highest usable field on a fully featured benchtop NMR on the market. In early 2025, the Company launched its new 60MHz instrument which is based on the successful 100MHz product line. The Company's devices are used in many industries (oil and gas, chemical, mining, pharma, biotech, flavor and fragrances, agrochemicals, law enforcement, and more) as well as numerous government and university research labs around the world. The Company is working to expand into new global market opportunities independently and with partners. With its partners, the Company provides scientific equipment sales and maintenance services globally. Within the Company's Security Services business, the core activity is providing airport security equipment maintenance in each province and territory of Canada. In addition, the Company provides commercial security equipment installation and maintenance services to a variety of customers in North America. Notice regarding Forward Looking Information and Legal Disclaimer This news release contains certain forward-looking information. All statements included herein, other than statements of historical fact, are forward-looking information and such information involves various risks and uncertainties. In particular, this news release contains forward-looking information in relation to: closing of the Offering; TSXV approval of the Notes and issuance of Bonus Shares; the use of proceeds of the Offering; payment of interest on the Notes in cash or common shares, subject to TSXV approval; the Company's payment of finder's fees in connection with the Offering; and investor participation in the Offering. There can be no assurance that such information will prove to be accurate, and actual results and future events could differ materially from those anticipated in such information. This forward-looking information reflects Nanalysis's current beliefs and is based on information currently available to Nanalysis and on assumptions Nanalysis believes are reasonable. These assumptions include, but are not limited to: the current share price of Nanalysis's common shares; TSXV acceptance and market acceptance of the offering; Nanalysis' general and administrative costs remaining constant; and market acceptance of Nanalysis's business model, goals and approach. Forward-looking information is subject to known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Nanalysis to be materially different from those expressed or implied by such forward-looking information. Statements with forward looking information are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. Readers should not place undue reliance on forward-looking information. Nanalysis does not undertake to update any forward-looking information except in accordance with applicable securities laws. This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to, or for the account or benefit of, U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws, unless an exemption from such registration is available. Neither the TSXV nor its Regulation Services Provider (as that term is defined in policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release. SOURCE Nanalysis Scientific Corp. View original content to download multimedia: Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
